NORCROSS, Ga., July 26, 2016 /PRNewswire/ -- For the second consecutive year, HIBICLENS® antiseptic skin cleanser was the most recommended antibacterial soap by pharmacists, according to the 2016 Pharmacy Times and US News & World Report Survey of Pharmacists' OTC Recommendations.
At a time when super bugs and antibiotic-resistant bacteria are garnering headlines and alcohol-based hand sanitizers are under increased scrutiny by the Food & Drug Administration for effectiveness, prevention has never been more important. HIBICLENS® is recognized as strong enough for medical care, gentle enough for motherly care. Whether incorporated into a daily skin cleansing routine, or used once as a skin antisepsic as part of a pre-operative plan, washing with HIBICLENS® at home kills germs on contact.1
HIBICLENS can continue working for up to 24 hours2 unlike alcohol-based hand sanitizers that have no on-going antimicrobrial effect once they have dried. This long lasting HIBICLENS point of difference is particularly important when you consider that the average person comes in contact with 300 surfaces every 30 minutes, which exposes them to 840,000 germs.3
In addition, HIBICLENS® is proven to be gentle enough for even sensitive skin4 and washes clean, leaving a layer of protection without any sticky residue.
HIBICLENS® is widely available nationwide in the first aid aisle of drug stores, mass merchandisers, and grocery chains, including CVS, Walgreens, Rite Aid, Target, Walmart and Publix. HIBICLENS® has a 40-year heritage in the hospital setting as a preoperative bathing product and for hand hygiene.
During the January to April survey period, participating pharmacists recommended antibacterial soaps an average of 646,500 times each month and HIBICLENS® was the recommendation 38% of the time among nine brand name products that garnered at least 1% of recommendations.5
"Pharmacists are an important source of OTC recommendations for consumers," said Janet Carter Smith, Vice President, Retail, for Mölnlycke Health Care. "We are pleased that pharmacists, one of the most trusted health care professionals among consumers, consistently recognize the important benefit HIBICLENS® provides to consumers who are concerned about eliminating germs that can cause infections and illness."
Consumers can learn more about HIBICLENS® on the brand's website, www.hibiclens.com, and can view a recently recorded Lifetime television segment on HIBICLENS® at the following: http://www.thebalancingact.com/molnlycke-health-care-2/
The annual survey of brand name over-the-counter products, conducted by Pharmacy Times and U.S. News & World Report, analyizes the collective recommendations of thousands of pharmacists for more than 1,100 over-the-counter brands, representing over 150 product categories, from pain and inflammation to cough and cold and topicals such as antibacterial soaps.
About Mölnlycke Health Care U.S.
Mölnlycke Health Care is a world-leading provider of single-use surgical and wound care solutions used by clinicians and patients in all healthcare settings, from hospitals to homes. Established in 1849 in Sweden, Mölnlycke supplies innovative, high quality medical products under the trusted brand names of Biogel®, Hibiclens®, Tortoise™, Mepilex®, Mepitel® and Mepiform®. Mölnlycke's U.S. Regional Headquarters is located in Norcross, Georgia. More information on HIBICLENS® and all Mölnlycke Health Care products can be found at www.molnlycke.com; please select the US site.
For Media Inquiries:
Mölnlycke Health Care, US Communications
Phone: (412) 327-5540
1 – Chapter 15, Chlorhexidine, Graham Denton
2 – MBT Study No. 582-106 Study Protocol # 5220.127.116.11.12
3 – The 2011 Tork Report
4 – Comparative Evaluation of Five Surgical Hand Scrub Preparations. AORN Journal 1994; Vol 60, No 2:246-256
5 – OTC Guide, 2016, Pharmacy Times and US News and World Report
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hibiclens-ranked-1-pharmacist-recommended-among-antibacterial-soaps-300302783.html
SOURCE Mölnlycke Health Care U.S.